Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

FMED vs GXDW: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to GXDW's −13.8%; 0% of their weight is in the same names.

askIQ about this page

askIQ about FMED and GXDW

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $6.0m on Oct 12, 2026 for Global X Dorsey Wright Thematic ETF.

At a glance
21.8%
FMED in the S&P 500
0.0%
GXDW in the S&P 500
+27.4%
FMED total return, 1 year
−13.8%
GXDW total return, 1 year
FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500
78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 33% of the fund · 72 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

GXDW · 1 year to Nov 4, 2026 100% of its weight is outside the S&P 500
100% of its weight is outside the S&P 5000% of GXDW's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 100% of the fund · 5 holdings as filed for Aug 31, 2026 · Nasdaq-100: 0% in100% of its weight is outside the S&P 5000% of GXDW's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · Nasdaq-100: 0% in

0% of GXDW's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

Both cost 0.50% a year; their one-year returns differ by 41.2 points.

FMED vs GXDW: Holdings Overlap & Returns
MeasureFMEDGXDW
Return
Total return, 1 year+27.4%−13.8%
Drawdown
Below its all-time high61.7%, high on Feb 10, 2021
Benchmark
What it tracksBroad innovation and megatrendsBroad innovation and megatrends
Cost and size
Expense ratio0.50%0.50%
Net assets, FMED as of Sep 30, 2026 and GXDW as of Oct 12, 2026$52m$6.0m
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, FMED and GXDW hold 0% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first FMED GXDW
Only in one fund ↓
Only in FMED
10X GENOMICS INC 5.19%
THERMO FISHER SCIENTIFIC INC 3.83%
DANAHER CORP 3.73%
NATERA INC 3.30%
ARGENX SE 3.20%
LIFESTANCE HEALTH GROUP INC 3.00%
REVOLUTION MEDICINES INC 2.87%
ILLUMINA INC 2.82%
Only in GXDW
Global X Cybersecurity ETF 21.19%
Global X Lithium & Battery Tech ETF 20.36%
Global X Artificial Intelligence & Technology ETF 20.15%
Global X Hydrogen ETF 19.58%
Global X Internet of Things ETF 18.70%
Check overlap with more funds →

Window by window

Window by window: FMED vs GXDW: Holdings Overlap & Returns
Total return
WindowFMEDGXDW
3 months+14.9%−4.0%
6 months+31.2%−20.3%
1 year+27.4%−13.8%
3 years+57.8%+7.4%
Since launchNot the same days: FMED Jun 2023 · GXDW Nov 2019+31.7%−3.6%

Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies GXDW Global X Dorsey Wright Thematic ETF · Holds 5 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companies
Theme Broad innovation and megatrends Broad innovation and megatrends
In the S&P 500 21.8% 0.0%
Active share vs the S&P 500 97.5% 100.0%
In the Nasdaq-100 5.1% 0.0%
Holdings 72 5
Top ten, share of the fund 33.2% 100.0%
Expense ratio 0.50% 0.50%
Fee for the differing part 0.51% 0.50%
Total return, 1 year +27.4% −13.8%
vs its benchmark not measured not measured
Below its high −0.9% −61.7%
Net assets, FMED as of Sep 30, 2026 and GXDW as of Oct 12, 2026 $52m $6.0m

As of Nov 4, 2026. Source: ETFIQ.

0% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

GXDW

By weight, 0% of GXDW's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 100% of the fund across 5 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned −13.8% with distributions reinvested. It sits 61.7% below its all-time high of Feb 10, 2021.

Questions people ask

Do FMED and GXDW hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or GXDW?
FMED has 22% of its weight in S&P 500 names and GXDW has 0%, so GXDW differs more from the index.
Which is cheaper, FMED or GXDW?
FMED and GXDW both charge 0.50% a year, so neither is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, FMED against GXDW, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-gxdw

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.